Cardiovascular Diabetology is affiliated with Sackler Faculty of Medicine, Tel-Aviv University
Articles
Page 41 of 62
-
Citation: Cardiovascular Diabetology 2015 14:138
-
Effect of metformin monotherapy on cardiovascular diseases and mortality: a retrospective cohort study on Chinese type 2 diabetes mellitus patients
Many factors influence whether the first-line oral anti-diabetic drug, metformin, should be initiated to a patient with type 2 diabetes mellitus (T2DM) early in the course of management in addition to lifestyl...
Citation: Cardiovascular Diabetology 2015 14:137 -
High visceral fat with low subcutaneous fat accumulation as a determinant of atherosclerosis in patients with type 2 diabetes
Abdominal visceral obesity has been reported to be associated with cardiovascular risks than body mass index, waist circumference, and abdominal subcutaneous fat. On the other hand, there is evidence that subc...
Citation: Cardiovascular Diabetology 2015 14:136 -
Adverse cardiovascular outcomes between insulin-treated and non-insulin treated diabetic patients after percutaneous coronary intervention: a systematic review and meta-analysis
Type 2 diabetes mellitus (DM) patients have worse adverse cardiovascular outcomes after Percutaneous Coronary Intervention (PCI). However, the adverse cardiovascular outcomes between insulin-treated and non-in...
Citation: Cardiovascular Diabetology 2015 14:135 -
Corin is down-regulated and exerts cardioprotective action via activating pro-atrial natriuretic peptide pathway in diabetic cardiomyopathy
Diabetic cardiomyopathy (DCM), a fatal cardiovascular complication of diabetes mellitus, often leads to progressive heart failure, however its pathogenesis remains unclear. Corin, a cardiac serine protease, is...
Citation: Cardiovascular Diabetology 2015 14:134 -
Patients with coronary artery disease and diabetes need improved management: a report from the EUROASPIRE IV survey: a registry from the EuroObservational Research Programme of the European Society of Cardiology
In order to influence every day clinical practice professional organisations issue management guidelines. Cross-sectional surveys are used to evaluate the implementation of such guidelines. The present survey ...
Citation: Cardiovascular Diabetology 2015 14:133 -
Gender differences in the progression of target organ damage in patients with increased insulin resistance: the LOD-DIABETES study
The purpose of this study was to analyze the evolution of vascular, cardiac and renal target organ damage (TOD) in patients with increased insulin resistance over a 3.5 year follow-up and to investigate gender...
Citation: Cardiovascular Diabetology 2015 14:132 -
Clinical impact of diabetes mellitus in patients undergoing transcatheter aortic valve replacement
Diabetes mellitus (DM) and aortic stenosis (AS) are frequent findings in the elderly population. Data regarding the influence of DM on the outcomes of patients undergoing transcatheter aortic valve replacemen...
Citation: Cardiovascular Diabetology 2015 14:131 -
Impact of long-term steroid therapy on epicardial and pericardial fat deposition: a cardiac MRI study
Increased cardiac fat has been identified as a risk factor for coronary artery disease. Metabolic syndrome is associated with increased cardiac fat deposition. Steroids are known to imitate some effects of met...
Citation: Cardiovascular Diabetology 2015 14:130 -
Antidiabetic treatment with gliptins: focus on cardiovascular effects and outcomes
The traditional oral pharmacological therapy for type 2 diabetes mellitus (T2DM) has been based on the prescription of metformin, a biguanide, as first line antihyperglycemic agent world over. It has been demo...
Citation: Cardiovascular Diabetology 2015 14:129 -
Erratum to: Plasma levels of matrix metalloproteinase-2, -3, -10, and tissue inhibitor of metalloproteinase-1 are associated with vascular complications in patients with type 1 diabetes: the EURODIAB Prospective Complications Study
Citation: Cardiovascular Diabetology 2015 14:128 -
Successful metabolic adaptations leading to the prevention of high fat diet-induced murine cardiac remodeling
Cardiomyopathy is a devastating complication of obesity and type 2 diabetes mellitus (T2DM). It arises even in patients with normoglycemia (glycosylated hemoglobin, A1C ≤7 %). As obesity and T2DM are approachi...
Citation: Cardiovascular Diabetology 2015 14:127 -
Soluble RAGE and atherosclerosis in youth with type 1 diabetes: a 5-year follow-up study
Advanced glycation end products (AGEs) play a role in the development of late complications and atherosclerosis in diabetes by engaging the receptor for advanced glycation end products, RAGE. Receptor binding ...
Citation: Cardiovascular Diabetology 2015 14:126 -
Circulating interleukin-1β promotes endoplasmic reticulum stress-induced myocytes apoptosis in diabetic cardiomyopathy via interleukin-1 receptor-associated kinase-2
IL-1β was considered as an important inflammatory cytokine in diabetic cardiovascular complications. DCM is one of the major manifestations of diabetic cardiovascular complications whose specific mechanisms ar...
Citation: Cardiovascular Diabetology 2015 14:125 -
HbA1c below 7 % as the goal of glucose control fails to maximize the cardiovascular benefits: a meta-analysis
Whether lowering glycosylated haemoglobin (HbA1c) level below 7.0 % improves macro-vascular outcomes in diabetes remains unclear. Here, we aimed to assess the effect of relatively tight glucose control resulti...
Citation: Cardiovascular Diabetology 2015 14:124 -
Altered myocardial response in patients with diabetic retinopathy: an exercise echocardiography study
Type 2 diabetes mellitus (T2DM) complicated by retinopathy is associated with altered left ventricular (LV) structure and resting myocardial dysfunction unlike T2DM without retinopathy. The myocardial response...
Citation: Cardiovascular Diabetology 2015 14:123 -
Cohort comparison study of cardiac disease and atherosclerotic burden in type 2 diabetic adults using whole body cardiovascular magnetic resonance imaging
Whole body cardiovascular MR (WB CVMR) combines whole body angiography and cardiac MR assessment. It is accepted that there is a high disease burden in patients with diabetes, however the quantification of the...
Citation: Cardiovascular Diabetology 2015 14:122 -
Relationship of YKL-40 and adiponectin and subclinical atherosclerosis in asymptomatic patients with type 1 diabetes mellitus from a European Mediterranean population
The glycoprotein YKL-40 is a new marker of early inflammation and endothelial dysfunction. Adiponectin is a collagen-like protein with anti-atherogenic and anti-inflammatory effects. Increased concentrations o...
Citation: Cardiovascular Diabetology 2015 14:121 -
Long-term clinical outcome in patients with acute coronary syndrome and dysglycaemia
Diabetes and impaired glucose tolerance (IGT) are major risk factors for atherosclerosis including coronary artery disease (CAD). The present study’s aim was to investigate the importance of glucose tolerance ...
Citation: Cardiovascular Diabetology 2015 14:120 -
Impaired fasting glucose and left ventricular diastolic dysfunction in middle-age adults: a retrospective cross-sectional analysis of 2971 subjects
Left ventricular (LV) diastolic dysfunction (LVDD) is a well-established and early echocardiographic characteristic of diabetic cardiomyopathy. However, there are limited data on the association between impair...
Citation: Cardiovascular Diabetology 2015 14:119 -
Skin collagen advanced glycation endproducts (AGEs) and the long-term progression of sub-clinical cardiovascular disease in type 1 diabetes
We recently reported strong associations between eight skin collagen AGEs and two solubility markers from skin biopsies obtained at DCCT study closeout and the long-term progression of microvascular disease in...
Citation: Cardiovascular Diabetology 2015 14:118 -
Plasma leptin level is associated with cardiac autonomic dysfunction in patients with type 2 diabetes: HSCAA study
It has been shown that visceral fat accumulation is associated with autonomic dysfunction, though the precise mechanism remains unclear. A recent basic study found that leptin can directly modulate autonomic f...
Citation: Cardiovascular Diabetology 2015 14:117 -
Long-term changes in cardiovascular risk markers during administration of exenatide twice daily or glimepiride: results from the European exenatide study
The risk of cardiovascular morbidity and mortality is significantly increased in patients with diabetes; thus, it is important to determine whether glucose-lowering therapy affects this risk over time. Changes...
Citation: Cardiovascular Diabetology 2015 14:116 -
PROMETHEUS: an observational, cross-sectional, retrospective study of hypertriglyceridemia in Russia
Data regarding the prevalence of hypertriglyceridemia in the Russian population are lacking, despite triglyceride (TG)-mediated pathways being causal in cardiovascular disease. The prevalence of mixed dyslipid...
Citation: Cardiovascular Diabetology 2015 14:115 -
Short-term high glucose exposure impairs insulin signaling in endothelial cells
Hyperglycemia is the hallmark of diabetes and its cardiovascular complications. Insulin plays an important role in the regulation of vascular homeostasis and maintenance of endothelial function. Insulin signal...
Citation: Cardiovascular Diabetology 2015 14:114 -
Reduction in peripheral vascular resistance predicts improvement in insulin clearance following weight loss
The hyperinsulinemia of obesity is a function of both increased pancreatic insulin secretion and decreased insulin clearance, and contributes to cardiovascular risk. Whilst weight loss is known to enhance insu...
Citation: Cardiovascular Diabetology 2015 14:113 -
Lack of associations between betatrophin/ANGPTL8 level and C-peptide in type 2 diabetic subjects
Betatrophin has been suggested as an inducer of β-cell proliferation in mice in addition to its function in regulating triglyceride. Recent data showed that betatrophin was increased in Type 2 Diabetes (T2D), ...
Citation: Cardiovascular Diabetology 2015 14:112 -
Association between blood glucose variability and coronary plaque instability in patients with acute coronary syndromes
Blood glucose variability is receiving considerable attention as a new risk factor for coronary artery disease. This study aimed to investigate the association between blood glucose variability and coronary pl...
Citation: Cardiovascular Diabetology 2015 14:111 -
Adjustment of the GRACE score by HemoglobinA1c enables a more accurate prediction of long-term major adverse cardiac events in acute coronary syndrome without diabetes undergoing percutaneous coronary intervention
The Global Registry of Acute Coronary Events (GRACE) risk score is widely recommended for risk assessment in patients with acute coronary syndrome (ACS). Chronic hyperglycemia [hemoglobinA1c (HbA1c)] can indep...
Citation: Cardiovascular Diabetology 2015 14:110 -
The pleiotropic effects of metformin: time for prospective studies
The global prevalence of diabetes has risen to epidemic proportions and the trend is predicted to continue. The consequent burden of cardiovascular morbidity and mortality is a major public health concern and ...
Citation: Cardiovascular Diabetology 2015 14:109 -
Association between metabolic syndrome and multiple lesions of intracranial atherothrombotic stroke: a hospital-based study
With the increasing trend of metabolic syndrome (MetS) and atherothrombotic stroke (which can manifest as stroke lesion multiplicity), studies on the association between MetS and the clinical aspects of athero...
Citation: Cardiovascular Diabetology 2015 14:108 -
Alterations in lipid transfers to HDL associated with the presence of coronary artery disease in patients with type 2 diabetes mellitus
We previously showed that unesterified-cholesterol transfer to high-density lipoprotein (HDL), a crucial step in cholesterol esterification and role in reverse cholesterol transport, was diminished in non-diab...
Citation: Cardiovascular Diabetology 2015 14:107 -
Lack of correlation between the optimal glycaemic control and coronary micro vascular dysfunction in patients with diabetes mellitus: a cross sectional study
Coronary microvascular dysfunction (CMD) is associated with cardiovascular events in type 2 diabetes mellitus (T2DM). Optimal glycaemic control does not always preclude future events. We sought to assess the e...
Citation: Cardiovascular Diabetology 2015 14:106 -
Long-term effects of the multidisciplinary risk assessment and management program for patients with diabetes mellitus (RAMP-DM): a population-based cohort study
Studies on the long-term effectiveness of multidisciplinary risk-stratification based management in Chinese population were rare. This study aimed to evaluate the effectiveness of a multidisciplinary risk ass...
Citation: Cardiovascular Diabetology 2015 14:105 -
Involvement of Rho-associated protein kinase (ROCK) and bone morphogenetic protein-binding endothelial cell precursor-derived regulator (BMPER) in high glucose-increased alkaline phosphatase expression and activity in human coronary artery smooth muscle cells
Vascular calcification is an independent risk factor for cardiovascular disease. Diabetes mellitus increases the incidence of vascular calcification; however, detailed molecular mechanisms of vascular calcific...
Citation: Cardiovascular Diabetology 2015 14:104 -
Inhibition of DPP-4 reduces acute mortality after myocardial infarction with restoration of autophagic response in type 2 diabetic rats
Type 2 diabetes mellitus (T2DM) worsens the outcome after myocardial infarction (MI). Here, we hypothesized that inhibition of dipeptidyl peptidase-4 (DPP-4) improves survival after MI in T2DM by modifying aut...
Citation: Cardiovascular Diabetology 2015 14:103 -
Glucagon-like peptide-1 protects against ischemic left ventricular dysfunction during hyperglycemia in patients with coronary artery disease and type 2 diabetes mellitus
Enhancement of myocardial glucose uptake may reduce fatty acid oxidation and improve tolerance to ischemia. Hyperglycemia, in association with hyperinsulinemia, stimulates this metabolic change but may have d...
Citation: Cardiovascular Diabetology 2015 14:102 -
Sensitivity of various adiposity indices in identifying cardiometabolic diseases in Arab adults
Obesity is a recognized risk factor for various cardiometabolic diseases and several indices are used clinically to assess overall cardiometabolic risk. This study aims to determine the sensitivity of six anth...
Citation: Cardiovascular Diabetology 2015 14:101 -
Delay in treatment intensification increases the risks of cardiovascular events in patients with type 2 diabetes
The aim of the study was to evaluate the effect of delay in treatment intensification (IT; clinical inertia) in conjunction with glycaemic burden on the risk of macrovascular events (CVE) in type 2 diabetes (T...
Citation: Cardiovascular Diabetology 2015 14:100 -
Histone deacetylase (HDAC) inhibition improves myocardial function and prevents cardiac remodeling in diabetic mice
Recent evidence indicates that inhibition of histone deacetylase (HDAC) protects the heart against myocardial injury and stimulates endogenous angiomyogenesis. However, it remains unknown whether HDAC inhibiti...
Citation: Cardiovascular Diabetology 2015 14:99 -
Coronary microvascular function is independently associated with left ventricular filling pressure in patients with type 2 diabetes mellitus
Left ventricular (LV) diastolic dysfunction is known as an early marker of myocardial alterations in patients with diabetes. Because microvascular disease has been regarded as an important cause of heart failu...
Citation: Cardiovascular Diabetology 2015 14:98 -
MuRF2 regulates PPARγ1 activity to protect against diabetic cardiomyopathy and enhance weight gain induced by a high fat diet
In diabetes mellitus the morbidity and mortality of cardiovascular disease is increased and represents an important independent mechanism by which heart disease is exacerbated. The pathogenesis of diabetic car...
Citation: Cardiovascular Diabetology 2015 14:97 -
Interplay between ultrastructural findings and atherothrombotic complications in type 2 diabetes mellitus
Accelerated atherosclerosis is the main underlying factor contributing to the high risk of atherothrombotic events in patients with diabetes mellitus and atherothrombotic complications are the main cause of mo...
Citation: Cardiovascular Diabetology 2015 14:96 -
A study about the relevance of adding acetylsalicylic acid in primary prevention in subjects with type 2 diabetes mellitus: effects on some new emerging biomarkers of cardiovascular risk
To evaluate the relevance of adding acetylsalicylic acid (ASA) in primary prevention in subjects with type 2 diabetes mellitus.
Citation: Cardiovascular Diabetology 2015 14:95 -
Partial inhibition of the ubiquitin–proteasome system ameliorates cardiac dysfunction following ischemia–reperfusion in the presence of high glucose
Acute hyperglycemia co-presenting with myocardial infarction (in diabetic and non-diabetic individuals) is often associated with a poor prognosis. Although acute hyperglycemia induces oxidative stress that can...
Citation: Cardiovascular Diabetology 2015 14:94 -
The receptor for advanced glycation end products and risk of peripheral arterial disease, amputation or death in type 2 diabetes: a population-based cohort study
Patients with type 2 diabetes have a high risk for early and extensive development of peripheral arterial disease (PAD) and this excess risk is not explained by increased burden of traditional atherosclerotic ...
Citation: Cardiovascular Diabetology 2015 14:93 -
Chronic Rho-kinase inhibition improves left ventricular contractile dysfunction in early type-1 diabetes by increasing myosin cross-bridge extension
Impaired actin–myosin cross-bridge (CB) dynamics correlate with impaired left ventricular (LV) function in early diabetic cardiomyopathy (DCM). Elevated expression and activity of Rho kinase (ROCK) contributes...
Citation: Cardiovascular Diabetology 2015 14:92 -
Enhancement of insulin-mediated rat muscle glucose uptake and microvascular perfusion by 5-aminoimidazole-4-carboxamide-1-β-d-ribofuranoside
Insulin-induced microvascular recruitment is important for optimal muscle glucose uptake. 5-aminoimidazole-4-carboxamide-1-β-d-ribofuranoside (AICAR, an activator of AMP-activated protein kinase), can also induce...
Citation: Cardiovascular Diabetology 2015 14:91 -
Rutin administration attenuates myocardial dysfunction in diabetic rats
Oxidative stress plays a major role in diabetic cardiomyopathy pathogenesis. Anti-oxidant therapy has been investigated in preventing or treating several diabetic complications. However, anti-oxidant action on...
Citation: Cardiovascular Diabetology 2015 14:90 -
Vitamin D status is associated with skin autofluorescence in patients with type 2 diabetes mellitus: a preliminary report
Skin autofluorescence is a non-invasive measurement of advanced glycation end products (AGE), which are suggested to be one of the major agents in the pathogenesis and progression of diabetes related cardiovas...
Citation: Cardiovascular Diabetology 2015 14:89
Annual Journal Metrics
-
Citation Impact 2023
Journal Impact Factor: 8.5
5-year Journal Impact Factor: 8.9
Source Normalized Impact per Paper (SNIP): 1.855
SCImago Journal Rank (SJR): 2.621Speed 2023
Submission to first editorial decision (median days): 2
Submission to acceptance (median days): 56Usage 2023
Downloads: 2,523,778
Altmetric mentions: 3,115